cultur
supernat
subject
viral
rna
extract
use
high
pure
viral
nucleic
acid
kit
roch
diagnost
complementari
dna
cdna
synthes
use
superscript
iii
invitrogen
random
primer
randomli
amplifi
use
illustra
genomiphi
kit
ge
healthcar
life
scienc
cdna
librari
prepar
use
nextera
dna
sampl
prep
kit
illumina
sequenc
run
nucleotid
perform
miseq
illumina
use
miseq
reagent
sequenc
kit
illumina
assembl
nucleotid
sequenc
use
determin
homolog
sequenc
tblast
nation
center
biotechnolog
inform
web
site
avail
http
blastncbinlmnihgovblastcgi
sftsv
genom
detect
reversetranscript
polymeras
chain
reaction
rtpcr
total
rna
extract
patient
sera
use
high
pure
viral
rna
kit
roch
appli
scienc
revers
transcript
perform
readytogo
rtpcr
bead
ge
healthcar
use
random
nucleotid
hexam
pcr
perform
amplifi
sftsvspecif
cdna
fragment
pcr
primer
set
design
amplifi
nucleoprotein
np
region
sftsv
genom
supplementari
tabl
pcr
condit
follow
cycl
minut
follow
minut
cycl
second
second
second
follow
cycl
minut
vero
cell
inocul
patient
sera
viru
isol
cultur
day
examin
sftsv
antigen
detect
indirect
immunofluoresc
assay
ifa
polyclon
antibodi
rais
sftsv
recombin
np
rnp
rabbit
antisftsv
rnp
serum
produc
follow
sftsv
rnp
tag
histidinetag
cterminu
express
baculoviru
express
system
previous
describ
np
gene
sftsv
strain
genbank
access
artifici
synthes
antisftsv
rnp
serum
rais
rabbit
immun
purifi
sftsv
rnp
previous
describ
neutral
antibodi
sftsv
chines
isol
strain
japanes
isol
studi
detect
report
previous
except
target
viru
except
antigen
prepar
immunoglobulin
g
igg
antibodi
titer
sftsv
determin
indirect
ifa
use
sftsv
vero
cell
previous
describ
histopatholog
studi
formalinfix
paraffinembed
specimen
perform
use
hematoxylineosin
stain
immunohistochem
analysi
perform
previous
describ
modif
rabbit
antisftsv
rnp
serum
peroxidaselabel
polymerconjug
antirabbit
immunoglobulin
envisionhrp
dako
use
immunohistochem
analysi
primari
secondari
antibodi
respect
normal
rabbit
serum
lymph
node
necrot
lymphaden
without
sftsv
infect
use
neg
control
antibodi
tissu
specimen
respect
ishat
use
detect
sftsv
genom
rna
negativestrand
rna
report
previous
except
strandspecif
oligonucleotid
probe
design
l
segment
sftsv
genom
supplementari
tabl
sftsv
copi
number
determin
perform
quantit
realtim
rtpcr
analysi
rna
sampl
extract
paraffinembed
section
previous
describ
modif
amount
human
messeng
rna
mrna
dnasetr
rna
extract
section
also
determin
use
intern
refer
normal
primer
label
probe
shown
supplementari
tabl
cultur
supernat
vero
cell
inocul
sftsv
isol
first
patient
use
electron
microscop
analysi
sampl
fix
glutaraldehyd
fix
sampl
neg
stain
phosphotungst
acid
observ
use
transmiss
electron
microscop
jeol
tokyo
japan
first
diagnosi
sft
japan
made
public
announc
ministri
health
labor
welfar
japan
januari
physician
ask
volunt
inform
treat
patient
satisfi
follow
case
definit
fever
gastrointestin
tract
symptom
nausea
vomit
abdomin
pain
diarrhea
melena
thrombocytopenia
plateletsl
leukopenia
white
blood
cellsl
elev
level
aspart
aminotransferas
alanin
aminotransferas
lactat
dehydrogenas
absenc
caus
death
admiss
intens
care
unit
sever
symptom
inform
patient
collect
physician
retrospect
recruit
patient
suspect
sft
conduct
januari
march
written
inform
consent
obtain
patient
respons
rel
serum
sampl
collect
patient
futur
analys
clarifi
etiolog
store
hospit
respect
physician
use
present
studi
sent
depart
virolog
nation
institut
infecti
diseas
niid
tokyo
japan
virolog
analys
clinic
laboratori
data
patient
sft
also
sent
correspond
author
saijo
without
inform
made
possibl
identifi
individu
cdna
prepar
patient
sera
sampl
use
determin
sftsv
genom
sequenc
termin
sequenc
sftsv
genom
determin
rapid
amplif
cdna
end
race
end
perform
rtpcr
linker
ligat
use
dynaexpress
mirna
clone
kit
high
effici
biodynam
laboratori
tokyo
japan
purifi
rna
cultur
supernat
sftsv
vero
cell
subject
linker
ligat
accord
manufactur
protocol
next
linker
ligat
end
purifi
linker
ligat
rna
accord
manufactur
protocol
follow
rna
purif
nucleospin
rna
cleanup
xs
takara
bio
shiga
japan
linker
ligat
rna
revers
transcrib
accord
manufactur
protocol
superscript
iii
invitrogen
carlsbad
ca
use
either
forward
rt
primer
antiparallel
sequenc
linker
sequenc
pd
n
primer
random
hexam
rtpcr
perform
use
hot
start
highfidel
dna
polymeras
neb
ipswich
sftsv
genespecif
primer
supplementari
tabl
rt
primer
primer
antiparallel
sequenc
linker
sequenc
nucleotid
sequenc
full
segment
sftsv
patient
sera
align
use
muscl
en
suit
program
molecular
evolutionari
genet
analysi
softwar
mega
team
japan
evolutionari
distanc
estim
use
kimura
method
phylogenet
tree
construct
use
neighborjoin
method
robust
tree
test
use
bootstrap
replic
access
number
nucleotid
sequenc
sftsv
l
ssegment
describ
supplementari
tabl
serum
sampl
use
virolog
analysi
obtain
written
inform
consent
patient
surviv
respons
famili
member
die
clinic
laboratori
data
patient
sft
sent
correspond
author
without
person
identifi
inform
protocol
procedur
approv
research
ethic
committe
niid
polyclon
antibodi
sftsv
rnp
produc
immun
rabbit
purifi
sftsv
rnp
approv
institut
anim
care
use
committe
niid
previous
healthi
woman
age
year
live
yamaguchi
prefectur
japan
hospit
high
fever
fatigu
vomit
melena
autumn
bodi
temperatur
tick
bite
wound
observ
anywher
skin
laboratori
test
reveal
low
platelet
count
plateletsl
normal
rang
plateletsl
low
white
blood
cell
count
cellsl
normal
rang
cellsl
serum
level
alanin
aminotransferas
aspart
aminotransferas
creatin
kinas
abnorm
high
creactiv
protein
level
normal
coagul
studi
reveal
prolong
activ
partial
thromboplastin
time
high
ddimer
level
patient
serum
ferritin
level
extrem
elev
normal
rang
urinari
analysi
show
proteinuria
microhematuria
blood
cultur
steril
comput
tomographi
chest
abdomen
show
right
axillari
lymphadenopathi
bilater
renal
swell
howev
evid
hepatosplenomegali
bone
marrow
aspir
reveal
mildli
hypocellular
marrow
increas
level
activ
histiocyt
hemophagocyt
patient
condit
deterior
rapidli
day
follow
admiss
appear
macrohematuria
massiv
amount
tarri
stool
death
occur
third
day
hospit
serum
use
viru
isol
use
vero
feli
catu
whole
fetu
cell
cytopath
effect
appear
cell
within
day
mani
dna
fragment
homolog
sftsv
detect
cultur
supernat
cell
inocul
nextgener
sequenc
dna
amplifi
convent
rtpcr
use
either
primer
pair
show
expect
size
bp
agaroseelectrophoresi
data
shown
inocul
vero
cell
test
presenc
sftsv
antigen
indirect
ifa
rabbit
antisftsv
rnp
serum
show
similar
posit
reactiv
figur
envelop
spheric
virion
approxim
diamet
nm
detect
electron
microscopi
figur
morpholog
virion
compat
bunyaviru
viru
isol
patient
name
sftsv
autopsi
find
includ
right
axillari
lymphadenopathi
cm
figur
bilater
renal
swell
mild
retent
pericardi
fluid
ml
hepat
steatosi
gastric
ulcer
also
observ
pylor
region
sever
necrot
lymphaden
massiv
necrosi
deplet
small
lymphocyt
sever
infiltr
swollen
right
axillari
right
cervic
lymph
node
histiocyt
immunoblast
observ
figur
necrosi
compris
nuclear
debri
eosinophil
ghost
granulocyt
distribut
throughout
cortic
area
sinus
capsul
lymph
node
spread
perinod
adipos
tissu
cluster
epithelioid
histiocyt
stellat
microabscess
granuloma
observ
obviou
intranuclear
intracytoplasm
viral
inclus
promin
hemophagocytosi
observ
lymph
node
bone
marrow
spleen
figur
bone
marrow
rel
hypocellular
reduct
number
megakaryocyt
liver
show
mild
microvesicular
fatti
chang
zone
mild
inflamm
compris
lymphocyt
macrophag
around
portal
tract
kidney
show
subepitheli
hemorrhag
within
renal
pelvi
figur
signific
hemophagocytosi
also
observ
mediastin
hilar
abdomin
lymph
node
evid
necrosi
figur
find
remain
viscer
organ
unremark
posit
signal
sftsv
np
antigen
detect
cytoplasm
blastic
cell
necrot
region
cortic
area
right
axillari
lymph
node
figur
viral
antigenposit
cell
also
detect
right
cervic
lymph
node
figur
mediastin
lymph
node
figur
regardless
level
immunoblast
infiltr
hemophagocytosi
figur
rel
sftsv
cell
detect
bone
marrow
adren
gland
liver
spleen
figur
notabl
cytopath
effect
necrosi
antigenposit
cell
detect
heart
lung
kidney
gastrointestin
tract
aorta
iliopsoa
muscl
sftsv
genom
sftsv
genom
rna
negativestrand
rna
figur
mrna
positivestrand
rna
figur
detect
blastic
cell
right
cervic
lymph
node
ishat
analysi
signal
detect
use
irrelev
probe
neg
control
figur
signal
show
necrot
lymphaden
without
sftsv
infect
detect
lymph
node
neg
control
figur
sftsv
rna
present
high
copi
number
right
axillari
cervic
lymph
node
section
supplementari
tabl
consist
immunohistochem
analysi
result
low
copi
number
copi
sftsv
rna
also
detect
bone
marrow
spleen
liver
adren
gland
copi
detect
tissu
section
contain
antigenposit
cell
assess
immunohistochem
analysi
suggest
quantit
realtim
rtpcr
detect
cellfre
circul
sftsv
high
viral
load
serum
characterist
sft
infect
number
sftsv
rna
copiescel
calcul
use
mrna
copi
number
estim
copiescel
sftsv
rna
copi
number
right
axillari
cervic
lymph
node
section
highest
among
tissu
test
bone
marrow
spleen
liver
show
rel
lower
copi
number
per
cell
supplementari
tabl
serum
sampl
collect
patient
retrospect
suspect
sft
sent
depart
virolog
niid
figur
maletofemal
ratio
earliest
infect
date
back
figur
serum
sampl
collect
patient
patient
acut
phase
serum
sampl
avail
virolog
analysi
subject
viru
isol
rtpcr
amplif
sftsv
genom
serum
sampl
collect
patient
test
igg
immunoglobulin
igm
antibodi
sftsv
indirect
ifa
patient
men
women
receiv
diagnosi
sft
posit
result
viru
isol
genom
amplif
test
posit
result
viru
genom
amplif
test
igm
antibodi
sftsv
neg
result
viru
isol
analysi
posit
igg
antibodi
sftsv
present
studi
patient
test
posit
sftsv
basi
detect
igg
sfvsv
regard
sft
posit
symptom
reminisc
sft
report
asymptomat
case
china
quit
rare
purpos
present
studi
first
patient
includ
retrospect
case
total
diagnos
case
patient
sft
diagnos
age
year
figur
came
western
japan
figur
diseas
onset
occur
patient
month
april
decemb
figur
six
case
fatal
clear
evid
tick
bite
case
clinic
manifest
observ
sft
patient
summar
tabl
patient
show
nonspecif
febril
symptom
gastrointestin
tract
symptom
earli
phase
diseas
deterior
conscious
character
dysarthria
disorient
alter
conscious
commonli
observ
gener
convuls
seen
late
stage
diseas
fatal
case
respiratori
symptom
rare
observ
superfici
lymphadenopathi
detect
patient
hemorrhag
symptom
petechia
purpura
melena
bloodi
vomit
gingiv
bleed
form
discharg
excess
bleed
site
skin
biopsi
observ
patient
blood
urea
nitrogen
creatinin
level
elev
patient
hematuria
proteinuria
observ
patient
patient
bone
marrow
observ
perform
hemophagocytosi
without
bone
marrow
cell
dysplasia
observ
ferritin
level
elev
blood
patient
includ
bone
marrow
examin
perform
abnorm
observ
test
patient
coagulopathi
prothrombin
time
activ
partial
thromboplastin
time
fibrinfibrinogen
degrad
product
fibrinogen
andor
ddimer
japanes
sftsv
strain
close
relat
sftsv
chines
isol
form
independ
cluster
segment
figur
geograph
chronolog
relationship
found
japanes
chines
strain
sera
collect
surviv
patient
sft
convalesc
phase
show
neutral
activ
sftsv
japanes
isol
figur
sera
patient
also
show
similar
degre
neutral
activ
sftsv
clinic
manifest
japanes
sft
similar
sever
case
chines
sft
casefat
rate
patient
appar
higher
china
averag
case
fatal
worth
note
characterist
japanes
sft
present
studi
base
limit
number
patient
strict
case
definit
knowledg
may
first
report
describ
patholog
find
patient
sft
local
lymph
node
primari
target
organ
first
patient
serv
site
viru
replic
show
mark
patholog
chang
includ
massiv
necrosi
neutrophil
infiltr
observ
patient
spleen
liver
adren
gland
bone
marrow
contain
sftsvinfect
cell
howev
viral
antigen
detect
hepatocyt
parenchym
cell
adren
gland
virus
belong
bunyavirida
famili
includ
rift
valley
fever
viru
hantaan
viru
heartland
viru
infect
monocytesmacrophag
cell
may
control
spread
contain
virus
cell
within
organ
patholog
virolog
observ
suggest
sftsv
replic
blastic
cell
within
lymph
node
replic
took
place
predominantli
local
lymph
node
major
organ
macrophag
phagocytosi
bone
marrow
cell
observ
patient
bone
marrow
examin
perform
furthermor
patholog
examin
lymph
node
bone
marrow
spleen
initi
patient
reveal
mark
hemophagocytosi
regardless
presenc
sftsvinfect
cell
figur
figur
ferritin
level
extrem
elev
sera
patient
test
abnorm
coagulopathyassoci
indic
also
observ
patient
sftsv
infect
induc
cytokin
storm
level
associ
sever
sft
result
indic
addit
multiorgan
dysfunct
hemophagocytosi
dissemin
intravascular
coagul
major
factor
poor
prognosi
mode
natur
sftsv
lifecycl
japan
clarifi
enabl
better
identif
risk
factor
sftsv
infect
address
strategi
reduc
risk
infect
studi
necessari
clarifi
circul
sftsv
natur
japan
term
tick
speci
percentag
sftsv
posit
tick
speci
preval
sftsvposit
tick
better
determin
evalu
risk
factor
sftsv
infect
japan
japanes
isol
form
cluster
independ
chines
isol
figur
indic
sftsv
circul
japan
natur
time
earliest
year
evid
sft
patient
sera
sampl
knowledg
articl
liu
et
al
concern
sft
occurr
china
report
oldest
case
china
also
noteworthi
patient
sft
report
south
korea
prome
mail
archiv
number
preval
sft
around
east
asia
studi
clarifi
natur
sft
region
conclus
sftsv
preval
japan
japanes
sftsv
strain
characterist
similar
chines
isol
independ
genotyp
indic
sftsv
present
japan
time
